{ "cik": 1368514, "cik_padded": "0001368514", "entityName": "ADMA BIOLOGICS, INC.", "fiscal_years": [ { "accn": "0001140361-26-006815", "filed": "2026-02-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 31940000.0, "capex": 22575000.0, "cash": 87630000.0, "cost_of_revenue": 217408000.0, "eps_diluted": 0.6, "free_cash_flow": 27821000.0, "gross_profit": 292765000.0, "net_income": 146930000.0, "operating_cash_flow": 50396000.0, "operating_income": 191443000.0, "revenue": 510173000.0, "stockholders_equity": 477320000.0, "total_assets": 624242000.0, "total_liabilities": 146922000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5738543592075629, "leverage": 0.30780608396882597, "net_margin": 0.28800034498101623, "operating_margin": 0.37525114029946705, "revenue_growth_yoy": 0.19631425663729266, "roa_avg2y": 0.26404413614635375, "roa_period_end": 0.23537346093342004, "roe_avg2y": 0.35561719296462224, "roe_period_end": 0.3078228442135255 } }, { "accn": "0001140361-26-006815", "filed": "2026-02-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 8226000.0, "cash": 103147000.0, "cost_of_revenue": 206901000.0, "eps_diluted": 0.81, "free_cash_flow": 110446000.0, "gross_profit": 219553000.0, "net_income": 197673000.0, "operating_cash_flow": 118672000.0, "operating_income": 138983000.0, "revenue": 426454000.0, "stockholders_equity": 349018000.0, "total_assets": 488678000.0, "total_liabilities": 139660000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5148339563000933, "leverage": 0.4001512815957916, "net_margin": 0.4635271330553823, "operating_margin": 0.32590384894971086, "revenue_growth_yoy": 0.6515461921267162, "roa_avg2y": 0.4833908003814834, "roa_period_end": 0.40450562538113033, "roe_avg2y": 0.8164527160983347, "roe_period_end": 0.5663690697900968 } }, { "accn": "0001140361-26-006815", "filed": "2026-02-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 4771000.0, "cash": 51352000.0, "cost_of_revenue": 169273000.0, "eps_diluted": -0.13, "free_cash_flow": 4029000.0, "gross_profit": 88942000.0, "net_income": -28239000.0, "operating_cash_flow": 8800000.0, "operating_income": 21632000.0, "revenue": 258215000.0, "stockholders_equity": 135206000.0, "total_assets": 329182000.0, "total_liabilities": 193976000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.34444939294773735, "leverage": 1.4346700590210493, "net_margin": -0.10936235307786149, "operating_margin": 0.08377514861646303, "revenue_growth_yoy": 0.6758502076843198, "roa_avg2y": -0.08334477003377885, "roa_period_end": -0.08578537101056559, "roe_avg2y": -0.19666411309979803, "roe_period_end": -0.20885907430143633 } }, { "accn": "0001140361-26-006815", "filed": "2026-02-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13911000.0, "cash": 86522000.0, "cost_of_revenue": 118815000.0, "eps_diluted": -0.33, "free_cash_flow": -73419000.0, "gross_profit": 35265000.0, "net_income": -65904000.0, "operating_cash_flow": -59508000.0, "operating_income": -39365000.0, "revenue": 154080000.0, "stockholders_equity": 151974000.0, "total_assets": 348461000.0, "total_liabilities": 196487000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.2288746105919003, "leverage": 1.2928987853185414, "net_margin": -0.4277258566978193, "operating_margin": -0.2554841640706127, "revenue_growth_yoy": 0.9035617656869649, "roa_avg2y": -0.210989348725977, "roa_period_end": -0.18912876907315307, "roe_avg2y": -0.44963107246535017, "roe_period_end": -0.43365312487662355 } }, { "accn": "0001140361-25-009257", "filed": "2025-03-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13511000.0, "cash": 51089118.0, "cost_of_revenue": 79770000.0, "eps_diluted": -0.51, "free_cash_flow": -125880000.0, "gross_profit": 1173000.0, "net_income": -71648000.0, "operating_cash_flow": -112369000.0, "operating_income": -58374000.0, "revenue": 80943000.0, "stockholders_equity": 141173000.0, "total_assets": 276253000.0, "total_liabilities": 135080158.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.014491679329898817, "leverage": 0.9568413081821595, "net_margin": -0.8851661045427028, "operating_margin": -0.7211741595937882, "revenue_growth_yoy": 0.9171818102428428, "roa_avg2y": -0.29611114784534776, "roa_period_end": -0.25935645947736313, "roe_avg2y": -0.6245957231651716, "roe_period_end": -0.5075191431789364 } }, { "accn": "0001140361-24-010147", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 12726680.0, "cash": 55921152.0, "cost_of_revenue": 61291426.0, "eps_diluted": -0.88, "free_cash_flow": -114729638.0, "gross_profit": -19071643.0, "net_income": -75748548.0, "operating_cash_flow": -102002958.0, "operating_income": -64914877.0, "revenue": 42219783.0, "stockholders_equity": 88249000.0, "total_assets": 207673394.0, "total_liabilities": 119423968.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": -0.45172290440242197, "leverage": 1.3532614307244275, "roa_avg2y": -0.45254878704608126, "roa_period_end": -0.3647484472661915, "roe_avg2y": -1.3237875845900098, "roe_period_end": -0.8583502136001541 } }, { "accn": "0001193805-21-000411", "filed": "2022-03-24", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3811838.0, "cash": 26752135.0, "free_cash_flow": -80005342.0, "net_income": -48279317.0, "operating_cash_flow": -76193504.0, "operating_income": -41424327.0, "stockholders_equity": 26193149.0, "total_assets": 127090725.0, "total_liabilities": 100897576.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.8520597886111365, "roa_avg2y": -0.4470985104843167, "roa_period_end": -0.3798807269373906, "roe_avg2y": -2.1007636762552933, "roe_period_end": -1.8432039996412803 } }, { "accn": "0001193805-21-000411", "filed": "2021-03-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2095600.0, "cash": 26754852.0, "free_cash_flow": -64774282.0, "gross_profit": -25209345.0, "net_income": -65743445.0, "operating_cash_flow": -62678682.0, "operating_income": -60288944.0, "stockholders_equity": 19770438.0, "total_assets": 88876521.0, "total_liabilities": 69106083.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.495424987549593, "roa_avg2y": -0.6678008766016896, "roa_period_end": -0.7397166795041403, "roe_avg2y": -2.187685529862431, "roe_period_end": -3.3253408447501265 } }, { "accn": "0001193805-20-000348", "filed": "2020-03-13", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2676328.0, "cash": 43107574.0, "free_cash_flow": -39948102.0, "gross_profit": -6403761.0, "net_income": -43758975.0, "operating_cash_flow": -37271774.0, "operating_income": -39309996.0, "stockholders_equity": 40332757.0, "total_assets": 108018833.0, "total_liabilities": 67686076.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.6781911536570635, "roa_avg2y": -0.6645052882937014, "roa_period_end": -0.40510505237545014, "roe_avg2y": -2.439491078799052, "roe_period_end": -1.084948767573712 } }, { "accn": "0001193805-19-000281", "filed": "2019-03-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 73410.0, "cash": 9914867.0, "free_cash_flow": -18342383.0, "gross_profit": 4300276.0, "net_income": -19515151.0, "operating_cash_flow": -18268973.0, "operating_income": -17330395.0, "stockholders_equity": -4457262.0, "total_assets": 23685085.0, "total_liabilities": 28142347.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.8239426204296924 } }, { "accn": "0001193805-17-000330", "filed": "2017-02-24", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "gross_profit": "USD" }, "fundamentals": { "gross_profit": 2866172.0 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001193805-14-000641", "filed": "2014-03-28", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 150000.0 }, "period_end": "2012-12-31", "ratios": {} }, { "accn": "0001193805-13-000585", "filed": "2013-03-06", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 0.0 }, "period_end": "2011-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001140361-26-006815", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001368514.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001368514.json" }, "ticker": "ADMA" }